1. The changing role of beta-blocker therapy in patients with cirrhosis
Phillip S. Ge, Bruce A. Runyon 
Journal of Hepatology 
Volume 60, Issue 3, Pages (March 2014)
DOI: /j.jhep
Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

2. Fig. 1
The differential effect of beta-blockers in cirrhosis. Modified with permission from: Krag A, Wiest R, Albillos A, Gluud LL. The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease. Gut 2012;61:967–969. Copyright © 2012 BMJ Group.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

3. Fig. 2
Algorithmic approach for beta-adrenergic antagonists in patients with cirrhosis. BP, blood pressure; EGD, esophagogastroduodenoscopy.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

4. Journal of Hepatology 2014 60, 643-653DOI: (10. 1016/j. jhep. 2013. 09
Copyright © 2013 European Association for the Study of the Liver Terms and Conditions